Huma secures $80M in Series D funding, launches its cloud platform

Huma team L to R Milano Fili – Dan Vahdat – Giannis Anastasiadis – Tobias Alpsten

Global healthcare AI company Huma Therapeutics has received over $80 million in Series D funding.
New and existing strategic and financial investors participated in this round, including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer.
This round, combined with investments from industry partners since its Series C round, brings Huma’s total raised capital to over $300 million.
Additionally, Huma is launching the Huma Cloud Platform, a technology ecosystem designed to accelerate the development and launch of digital health projects.
The Huma Cloud Platform offers no-code configuration for regulated disease management tools, a library of pre-built modules, device connectivity capabilities, cloud-agnostic hosting, readily available APIs, integration capabilities, and the ability to host and deploy diagnostic and predictive AI algorithms. This suite aims to advance digital-first care and research, reducing the time to develop and launch digital health products from years to mere days.
Now available to customers, the platform comes equipped with a Software Development Kit (SDK) to facilitate the accelerated development of similar applications or embed functionalities into existing solutions.
Huma’s technology has powered projects in over 3,000 hospitals and clinics, engaging and screening over 35 million individuals, with 1.8 million active users across its products in more than 70 countries.
Huma collaborates with over half of the top 20 pharmaceutical companies globally and has been involved in major national healthcare projects. Partnerships with organizations like Google have facilitated the development of new AI models, such as the “10x Nurse” feature, which reduces administrative tasks and brings automation to the patient review process, maintaining human oversight. These advancements enable more efficient management of chronic diseases and real-time monitoring systems to ensure patients are on the correct treatment pathways.
Looking ahead, the combination of the Huma Cloud Platform with next-generation AI models promises to have a profound impact on digital-first care and research initiatives. It will support small startups and enterprises in launching the digital solutions they need, emphasizing project or venture success over scaling technology or managing regulatory burdens.